| Ytd | 17.08% | |
| 1y | 18.69% |
| Open | 69.11 | Prev Close | 69.43 | Low | 68.28 | High | 69.67 | Mkt Cap | 2.38B |
| Vol | 292.96K | Avg Vol | 261.61K | EPS | 0.71 | P/E | 97.59 | Forward P/E | 11.52 |
| Beta | 1.18 | Short Ratio | 5.04 | Inst. Own | 105.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 73.56 | 200-d Avg | 68.12 | 1yr Est | 89.00 |
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Ingevity is transforming into a focused, high-margin regulatory compounder, emphasizing Performance
NGVT's raised 2026 outlook, portfolio transformation and new growth platforms support its momentum a
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity included in TIME America's Best Companies 2026 lis
Ingevity's Q2 earnings beat estimates as pricing, mix and higher volumes lifted margins, prompting h
Ingevity Corporation (NYSE: NGVT) today announced it has published its [url="]2025 Sustainability Re
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation has published its 2025 Sustainability
Ingevity NYSE: NGVT reported second-quarter 2026 results marked by higher adjusted earnings, margin
Bank of New York Mellon Corp reduced its stake in shares of Ingevity Corporation (NYSE: NGVT) by 6.1
Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
Ingevity (NGVT) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Est
Ingevity (NYSE:NGVT) raises FY2026 Adj EPS guidance from $4.70-$5.20 to $5.00-$5.45 vs $5.01 analyst
Ingevity (NYSE:NGVT) reported quarterly earnings of $1.74 per share which beat the analyst consensus
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity raises full year Adjusted EBITDA outlook following
Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mi
Approval reflects alignment with evolving regulatory and performance standard for German market requ
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Evotherm® P35 warm-mix additive has rece
NGVT shares are up 24.8% YTD, beating the industry, as portfolio optimization, hybrid demand and pri
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Dave Li, president and CEO, will speak a
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?
Ingevity NYSE: NGVT reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as
Ingevity beats Q1 estimates as pricing actions and FX gains lift sales and earnings, despite weaknes
Ingevity Corporation (NGVT) Q1 2026 Earnings Call Transcript
Ingevity (NYSE:NGVT) widens FY2026 Adj EPS guidance from $4.80-$5.20 to $4.70-$5.20 vs $4.80 analyst
Ingevity (NYSE:NGVT) reported quarterly earnings of $1.15 per share which beat the analyst consensus
PPG (NYSE:PPG) today announced that it has completed the acquisition of Ozark Materials, LLC, a U.S.
Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises t
Ingevity (NYSE:NGVT) is looking for FY2026 Adj EPS of $4.80-$5.20 vs $4.71 analyst estimate. sees sa
Ingevity (NYSE:NGVT) reported quarterly earnings of $0.64 per share which missed the analyst consens
Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises t
Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises t
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the
Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises t
Ingevity (NYSE:NGVT) narrows FY2025 sales outlook from $1.250 billion-$1.400 billion to $1.250 billi
Ingevity (NYSE:NGVT) reported quarterly earnings of $1.31 per share which missed the analyst consens
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the
Divestiture reduces portfolio volatility, strengthens Ingevity's margin and cash flow profile an
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the
Ingevity (NYSE:NGVT) affirms FY2025 sales outlook from $1.250 billion-$1.400 billion to $1.250 billi
Ingevity (NYSE:NGVT) reported quarterly earnings of $1.39 per share which beat the analyst consensus
Wells Fargo analyst Michael Sison maintains Ingevity (NYSE:NGVT) with a Equal-Weight and raises t
Ingevity Corporation (NYSE:NGVT) today announced the expansion of its Capa® caprolactone distributio